A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of ENX-102 and Determine a Dose-response for ENX-102 in Patients With Generalized Anxiety Disorder (GAD)
Latest Information Update: 25 Oct 2024
At a glance
- Drugs ENX 102 (Primary)
- Indications Generalised anxiety disorder
- Focus Adverse reactions
- Sponsors Engrail Therapeutics
- 25 Oct 2024 New trial record